Literature DB >> 26227535

Molecular imaging of cholinergic processes in prostate cancer using ¹¹C-donepezil and ¹⁸F-FEOBV.

Morten Gersel Stokholm1, Søren Høyer2, Michael Borre3, Dirk Bender4, Steen Jakobsen4, Jørgen Frøkiær4, Per Borghammer4.   

Abstract

PURPOSE: High-grade prostate cancer (PC) displays parasympathetic neoneurogenesis. We investigated the binding of two PET tracers that visualize cholinergic nerves in PC tissue using autoradiography.
METHODS: Prostatectomy tissue was subjected to autoradiography with (11)C-donepezil and (18)F-FEOBV and correlated with Gleason scores (GS). Regions of interest on the autoradiograms were defined and quantified. Tracer binding in cancer tissue regions was compared with that in normal tissue.
RESULTS: We included 13 patients with biopsy-verified PC. In particular, (11)C-donepezil uptake was higher in "high-grade" PC (GS ≥4 + 3) than in "low-grade" PC and benign hyperplasia. (11)C-donepezil uptake ranged from a mean of 56 % higher (GS 3 + 3) to 409 % higher (GS 4 + 4), and (18)F-FEOBV uptake ranged from 67 % higher (GS 3 + 3) to 194 % higher (GS 4 + 5). The uptake of both tracers was higher in PC with a high GS than in PC with a low GS, but the difference was significant only for (11)C-donepezil (p = 0.003).
CONCLUSION: Uptake of PET tracers binding to cholinergic nerves was markedly higher in PC with a high GS than in PC with a low GS. This finding implies that (11)C-donepezil PET/CT may be able to differentiate between low-grade and high-grade PC.

Entities:  

Keywords:  Acetylcholinesterase; Autoradiography; Positron emission tomography; Prostate cancer; Vesicular acetylcholine transporter

Mesh:

Substances:

Year:  2015        PMID: 26227535     DOI: 10.1007/s00259-015-3143-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  16 in total

1.  Radical prostatectomy versus observation for localized prostate cancer.

Authors:  Timothy J Wilt; Michael K Brawer; Karen M Jones; Michael J Barry; William J Aronson; Steven Fox; Jeffrey R Gingrich; John T Wei; Patricia Gilhooly; B Mayer Grob; Imad Nsouli; Padmini Iyer; Ruben Cartagena; Glenn Snider; Claus Roehrborn; Roohollah Sharifi; William Blank; Parikshit Pandya; Gerald L Andriole; Daniel Culkin; Thomas Wheeler
Journal:  N Engl J Med       Date:  2012-07-19       Impact factor: 91.245

Review 2.  Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review.

Authors:  Caroline M Moore; Nicola L Robertson; Nasr Arsanious; Thomas Middleton; Arnauld Villers; Laurence Klotz; Samir S Taneja; Mark Emberton
Journal:  Eur Urol       Date:  2012-06-13       Impact factor: 20.096

3.  In vivo imaging of human cholinergic nerve terminals with (-)-5-(18)F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses.

Authors:  Myria Petrou; Kirk A Frey; Michael R Kilbourn; Peter J H Scott; David M Raffel; Nicolaas I Bohnen; Martijn L T M Müller; Roger L Albin; Robert A Koeppe
Journal:  J Nucl Med       Date:  2014-01-30       Impact factor: 10.057

Review 4.  Critical roles of acetylcholine and the muscarinic and nicotinic acetylcholine receptors in the regulation of immune function.

Authors:  Koichiro Kawashima; Takeshi Fujii; Yasuhiro Moriwaki; Hidemi Misawa
Journal:  Life Sci       Date:  2012-05-29       Impact factor: 5.037

5.  Significant discrepancies between diagnostic and pathologic Gleason sums in prostate cancer: the predictive role of age and prostate-specific antigen.

Authors:  Brandon K Isariyawongse; Leon Sun; Lionel L Bañez; Cary Robertson; Thomas J Polascik; Kelly Maloney; Craig Donatucci; David Albala; Vladimir Mouraviev; John F Madden; Judd W Moul
Journal:  Urology       Date:  2008-04-02       Impact factor: 2.649

6.  Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET.

Authors:  Trine Gjerløff; Tatyana Fedorova; Karoline Knudsen; Ole L Munk; Adjmal Nahimi; Steen Jacobsen; Erik H Danielsen; Astrid J Terkelsen; John Hansen; Nicola Pavese; David J Brooks; Per Borghammer
Journal:  Brain       Date:  2014-12-23       Impact factor: 13.501

7.  Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.

Authors:  B J Vilner; C S John; W D Bowen
Journal:  Cancer Res       Date:  1995-01-15       Impact factor: 12.701

8.  Autonomic nerve development contributes to prostate cancer progression.

Authors:  Claire Magnon; Simon J Hall; Juan Lin; Xiaonan Xue; Leah Gerber; Stephen J Freedland; Paul S Frenette
Journal:  Science       Date:  2013-07-12       Impact factor: 47.728

Review 9.  18F-Choline, 11C-choline and 11C-acetate PET/CT: comparative analysis for imaging prostate cancer patients.

Authors:  Claudia Brogsitter; Klaus Zöphel; Jörg Kotzerke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-12       Impact factor: 9.236

10.  Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.

Authors:  Derek J Rosario; J Athene Lane; Chris Metcalfe; Jenny L Donovan; Andy Doble; Louise Goodwin; Michael Davis; James W F Catto; Kerry Avery; David E Neal; Freddie C Hamdy
Journal:  BMJ       Date:  2012-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.